Ondansetron

Generic Name
Ondansetron
Brand Names
Zofran, Zuplenz
Drug Type
Small Molecule
Chemical Formula
C18H19N3O
CAS Number
99614-02-5
Unique Ingredient Identifier
4AF302ESOS
Background

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
...

Indication

In the adult patient population:

i) orally administered ondansetron tablets and orally disintegrating tablets (ODT) are indicated for:

- the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including high dose (ie. greater than or equal to 50 mg/m2) cisplatin therapy, and radiotherapy, and
...

Associated Conditions
Chemotherapy-Induced Nausea and Vomiting, Cholestatic pruritus, Post Operative Nausea and Vomiting (PONV), Radiation-Induced Nausea and Vomiting, Uremic Pruritus, Severe Hyperemesis gravidarum
Associated Therapies
-
Clinical Trials
Related News

Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy

First Posted Date
2016-04-08
Last Posted Date
2021-08-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
37
Registration Number
NCT02732015
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Effects of Systemic or Adjunct Tramadol Addition to Lidocaine Used for IVRA in Patients Undergoing Hand Surgery

First Posted Date
2016-01-20
Last Posted Date
2016-01-20
Lead Sponsor
Bagcilar Training and Research Hospital
Target Recruit Count
60
Registration Number
NCT02658721

The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine

First Posted Date
2016-01-15
Last Posted Date
2017-12-11
Lead Sponsor
University Medical Center of Southern Nevada
Target Recruit Count
54
Registration Number
NCT02657031
Locations
🇺🇸

University Medical Center of Southern Nevada, Las Vegas, Nevada, United States

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Not Applicable
Completed
Conditions
Postoperative Nausea and Vomiting
Interventions
Procedure: Automated recommendation at the start of the case
Procedure: Automated notification at the start of surgery
Procedure: Automated notification at the end of surgery
Device: Anesthesia Information Management System (AIMS)
Device: Perioperative Data Warehouse (PDW)
Procedure: General anesthesia
Procedure: Elective surgery
Drug: Propofol
Drug: Sevoflurane
Drug: Isoflurane
Drug: Desflurane
Drug: Scopolamine
Drug: Droperidol
Drug: Haloperidol
Drug: Dexamethasone
Drug: Promethazine
Drug: Meclizine
Drug: Aprepitant
Drug: Metoclopramide
Drug: Fentanyl
Drug: Sufentanil
Drug: Alfentanil
Drug: Remifentanil
Drug: Morphine
Drug: Meperidine
Drug: Hydromorphone
Drug: Methadone
Drug: Oxycodone
Drug: Oxymorphone
Drug: Hydrocodone
Drug: Ketamine
Drug: Ondansetron
Drug: Granisetron
Drug: Dolasetron mesylate
Drug: Palonosetron
Drug: Tropisetron
Drug: Ramosetron
First Posted Date
2015-12-09
Last Posted Date
2019-03-07
Lead Sponsor
Vanderbilt University
Target Recruit Count
27034
Registration Number
NCT02625181
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Antiemetic Efficacy of Ondansetron Versus Metoclopramide

First Posted Date
2015-12-02
Last Posted Date
2015-12-02
Lead Sponsor
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
Target Recruit Count
250
Registration Number
NCT02619201

EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron

Not Applicable
Completed
Conditions
Nausea
Interventions
Drug: Ondansetron
Drug: IPA
First Posted Date
2015-12-01
Last Posted Date
2021-03-24
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
51
Registration Number
NCT02618343
Locations
🇺🇸

San Antonio Fire Department EMS Division, San Antonio, Texas, United States

Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia

First Posted Date
2015-11-25
Last Posted Date
2017-05-01
Lead Sponsor
Takeda
Target Recruit Count
11
Registration Number
NCT02614586

Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

First Posted Date
2015-11-10
Last Posted Date
2021-09-23
Lead Sponsor
Stanford University
Target Recruit Count
120
Registration Number
NCT02601027
Locations
🇺🇸

Stanford University Medical Center, Stanford, California, United States

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for the Prophylaxis of Postoperative Nausea and Vomiting (PONV) in Women Over 60 Years Undergoing Laparoscopic Cholecystectomy

First Posted Date
2015-09-04
Last Posted Date
2017-08-09
Lead Sponsor
Hospital Federal de Bonsucesso
Target Recruit Count
80
Registration Number
NCT02541019
Locations
🇧🇷

Hospital Federal de Bonsucesso, Rio de Janeiro, Brazil

Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)

First Posted Date
2015-08-11
Last Posted Date
2019-03-15
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
75
Registration Number
NCT02519842
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy